The next webinar in the ACCP/ASHP Oncology Pharmacy Webinar Series, “A Review of Oral Hypomethylating Agents in MDS and AML,” is now available to purchase. Presented by Danielle Schlafer, Pharm.D., BCOP, the content includes the use of oral hypomethylating agents in case-based examples, decitabine/cedazuridine in MDS, oral azacitidine in patients with AML, dosing and administration for these agents, and related ongoing or upcoming clinical trials. The webinar recording is available for 1.5 hours of continuing pharmacy education or Board-Certified Oncology Pharmacist (BCOP) recertification credit.

The ACCP/ASHP Oncology Pharmacy Webinar Series is part of the professional development program for the recertification of BCOPs. The target audience for this webinar is pharmacists interested in learning more about updated information regarding oncologic management and/or treatment and BCOPs looking to earn recertification credit.

Registration is $99 for all ACCP members and $159 for nonmembers. Click here to purchase today!